UnknownNot Applicable

Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI

Egypt79 participantsStarted 2023-02-20

Plain-language summary

GnRH antagonist protocol is currently a good strategy for controlled ovarian stimulation in women with PCOS undergoing IVF/ICSI cycles. Finding a protocol that can be a better alternative will help in improving the success rate of IVF/ICSI cycles

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All patients should be candidates for ICSI.
✓. Age between 20-40 years.
✓. Body mass index 18-35 kg/m2.
✓. Diagnosis of PCOS according to modified Rotterdam's criteria

What they're measuring

Efficacy (Number of MII oocytes retrieved)

Timeframe: 3 months

Efficacy (Maturation index)

Timeframe: 3 months

Trial details

NCT IDNCT05751681

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-04-20

Contact for this trial

mostafa fahmy, mcs

01065644434 mafahmy21@gmail.com

View on ClinicalTrials.gov More Ovary Cyst trials